Yet another milestone: AF TRANS Polska received GDP certification by Bureau Veritas

For pharmaceutical companies, logistics failures are not operational inconveniences but regulatory and reputational risks.

Most pharmaceutical products have defined temperature requirements. Even minor deviations can compromise product quality and, ultimately, patient safety, something that is unacceptable in pharmaceutical supply chains. Such deviations may result in batch rejection or recall, regulatory reporting obligations, and supply disruption. This is why GDP (Good Distribution Practice) remains one of the most important standards for companies involved in the distribution of pharmaceutical products.

AF TRANS Polska has successfully passed its primary GDP audit conducted by Bureau Veritas, one of the leading international certification bodies. GDP training was completed by both Sales and Operations departments.

What is GDP certification and why it exists

GDP defines the requirements for the proper handling, storage, and transportation of pharmaceutical and medical products across supply chain.

A GDP certificate confirms that a logistics provider and is aligned with regulatory expectations covering temperature management, team competence and responsibility across all parties involved in transportation and storage.

Within this framework, the freight forwarder plays a central operational role. GDP-compliant forwarding goes beyond shipment coordination and includes the selection of appropriate transport modes, temperature-control solutions, monitoring tools, and handling procedures tailored to pharmaceutical cargo. It also requires structured collaboration with carriers, warehouses, and service providers to minimize the risks of deviations, delays, or supply chain disruption.
For compliance, procurement, logistics, and C-level stakeholders, working with a GDP-certified partner simplifies audits, reduces qualification burden, and supports overall regulatory consistency throughout the supply chain.

For AF TRANS Polska, GDP certification is a step closer to a larger initiative. The company is actively building a dedicated pharmaceutical logistics offering:
  • A qualified pool of carriers and partners
  • A structured training and competency system
  • GDP-aligned documentation and audit procedures

Good Distribution Practice forms the basis of compliant pharmaceutical logistics, ensuring that products are handled and transported under controlled conditions.

Our GDP certification by Bureau Veritas reflects this approach as a defined operational standard for pharmaceutical logistics rather than a formal designation.